rdf:type |
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0021641,
umls-concept:C0030705,
umls-concept:C0184512,
umls-concept:C0332307,
umls-concept:C0443315,
umls-concept:C0549178,
umls-concept:C0574032,
umls-concept:C1514873,
umls-concept:C1979963,
umls-concept:C2003903,
umls-concept:C2587213
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-9
|
pubmed:abstractText |
As in type 1 diabetes, continuous subcutaneous insulin infusion (CSII) therapy is emerging as a promising therapeutic option in type 2 diabetes. However, the insulin requirement profiles of patients with type 2 diabetes when treated via CSII with rapid-acting insulin analogs have not been well investigated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1557-8593
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
271-81
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20210565-Adult,
pubmed-meshheading:20210565-Aged,
pubmed-meshheading:20210565-Aged, 80 and over,
pubmed-meshheading:20210565-Body Mass Index,
pubmed-meshheading:20210565-Diabetes Mellitus, Type 2,
pubmed-meshheading:20210565-Female,
pubmed-meshheading:20210565-Hemoglobin A, Glycosylated,
pubmed-meshheading:20210565-Humans,
pubmed-meshheading:20210565-Hypoglycemic Agents,
pubmed-meshheading:20210565-Infusions, Subcutaneous,
pubmed-meshheading:20210565-Insulin,
pubmed-meshheading:20210565-Male,
pubmed-meshheading:20210565-Middle Aged,
pubmed-meshheading:20210565-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion.
|
pubmed:affiliation |
Department of Biochemistry, Konkuk University School of Medicine, Seoul, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|